End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.154 SEK | +10.32% | +17.92% | -31.56% |
Apr. 26 | Cell Impact AB Signs Agreement Valued At SEK 3.2 Million | CI |
Apr. 25 | Cell Impact AB Announces Board and Committee Changes | CI |
Sales 2022 | 91.53M 8.48M | Sales 2023 | 47.66M 4.42M | Capitalization | 133M 12.33M |
---|---|---|---|---|---|
Net income 2022 | -104M -9.64M | Net income 2023 | -121M -11.21M | EV / Sales 2022 | 7.76 x |
Net cash position 2022 | 120M 11.12M | Net cash position 2023 | 57.14M 5.29M | EV / Sales 2023 | 1.59 x |
P/E ratio 2022 |
-7.96
x | P/E ratio 2023 |
-0.2
x | Employees | 80 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 75.94% |
1 day | +10.32% | ||
1 week | +17.92% | ||
Current month | -9.20% | ||
1 month | -9.20% | ||
3 months | -12.80% | ||
6 months | -78.00% | ||
Current year | -31.56% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vallin
CEO | Chief Executive Officer | 47 | 20-12-31 |
Human Resources Officer | 52 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 21-12-31 | |
Mats Franzén
CHM | Chairman | 55 | 22-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.167 | +8.44% | 8,201,287 |
24-04-30 | 0.154 | +10.32% | 2,681,748 |
24-04-29 | 0.1396 | +7.38% | 2,222,975 |
24-04-26 | 0.13 | +4.00% | 6,365,650 |
24-04-25 | 0.125 | -6.72% | 5,378,253 |
End-of-day quote Nasdaq Stockholm, April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-31.56% | 9.06M | |
+70.89% | 4.24B | |
+3.17% | 2.04B | |
+7.34% | 2.02B | |
-6.05% | 1.92B | |
-10.74% | 1.47B | |
+16.58% | 1.4B | |
-8.37% | 1.33B | |
-27.21% | 1.33B | |
-16.74% | 1.25B |
- Stock Market
- Equities
- CI Stock